1. Home
  2. BRKR

as 07-17-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.

Founded: N/A Country:
United States
United States
Employees: N/A City: BILLERICA
Market Cap: 9.8B IPO Year: 2000
Target Price: $83.71 AVG Volume (30 days): 930.9K
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield:
0.30%
Dividend Payout Frequency: Quarterly
EPS: 2.74 EPS Growth: 30.48
52 Week Low/High: $53.79 - $94.86 Next Earning Date: 08-01-2024
Revenue: $3,000,900,000 Revenue Growth: 14.49%
Revenue Growth (this year): 16.31% Revenue Growth (next year): 8.73%

BRKR Daily Stock ML Predictions

Stock Insider Trading Activity of Bruker Corporation (BRKR)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Requardt Hermann Fritz BRKR Director Mar 4 '24 Sell $90.10 13,772 $1,240,857.20 24,375 SEC Form 4
Requardt Hermann Fritz BRKR Director Mar 4 '24 Sell $89.61 1,228 $110,041.08 23,147 SEC Form 4
Busse Falko BRKR PRESIDENT, BIOSPIN GROUP Feb 28 '24 Sell $86.06 13,852 $1,192,103.12 47,129 SEC Form 4
Busse Falko BRKR PRESIDENT, BIOSPIN GROUP Feb 28 '24 Sell $84.97 12,770 $1,085,066.90 34,359 SEC Form 4
Busse Falko BRKR PRESIDENT, BIOSPIN GROUP Feb 28 '24 Sell $84.48 1,500 $126,720.00 32,859 SEC Form 4
Prause Burkhard BRKR PRES. & CEO, BRUKER BEST Feb 22 '24 Sell $83.30 15,319 $1,276,072.70 17,065 SEC Form 4

Share on Social Networks: